SLC35A2 gene product modulates paramyxovirus fusion events during infection

PLoS Pathog. 2025 Jan 10;21(1):e1012531. doi: 10.1371/journal.ppat.1012531. eCollection 2025 Jan.

Abstract

Paramyxoviruses are significant human and animal pathogens that include mumps virus (MuV), Newcastle disease virus (NDV) and the murine parainfluenza virus Sendai (SeV). Despite their importance, few host factors implicated in paramyxovirus infection are known. Using a recombinant SeV expressing destabilized eGFP (rSeVCdseGFP) in a loss-of-function CRISPR screen, we identified the CMP-sialic acid transporter (CST) gene SLC35A1 and the UDP-galactose transporter (UGT) gene SLC35A2 as essential for paramyxovirus infection. As expected, SLC35A1 knockout (KO) cells showed drastic reduction in infections with SeV, NDV and MuV due to the lack of cell surface sialic acids receptors. However, SLC35A2 KO cells revealed unknown critical roles for this factor in virus-cell and cell-to-cell fusion events for the different paramyxoviruses. While UGT was essential for virus-cell fusion during SeV entry to the cell, it was not required for NDV or MuV entry. Importantly, UGT promoted the formation of syncytia during MuV infection, suggesting a role in cell-to-cell virus spread. Our findings demonstrate that paramyxoviruses can bind to or enter A549 cells in the absence of canonical galactose-bound sialic-acid decorations and show that UGT facilitates paramyxovirus fusion processes involved in entry and spread.

MeSH terms

  • A549 Cells
  • Animals
  • Humans
  • Monosaccharide Transport Proteins / genetics
  • Monosaccharide Transport Proteins / metabolism
  • Newcastle disease virus / genetics
  • Newcastle disease virus / physiology
  • Nucleotide Transport Proteins / genetics
  • Nucleotide Transport Proteins / metabolism
  • Paramyxoviridae / genetics
  • Paramyxoviridae Infections / metabolism
  • Paramyxoviridae Infections / virology
  • Sendai virus / genetics
  • Virus Internalization*

Substances

  • Nucleotide Transport Proteins
  • Monosaccharide Transport Proteins
  • SLC35A1 protein, human

Grants and funding

C.L.B. was supported by NIH R01AI137062 and the BJC Investigator program at WUSTL. M.T.B. was supported by The G. Harold and Leila Y. Mathers Foundation and the Burroughs Wellcome Fund Pathogenesis of Infectious Disease Program. D.E.C. was supported by NIH T32 DK077653-29 and Crohn’s & Colitis Foundation Research Fellowship Award #935619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.